Cyclo Therapeutics, Inc.
Cyclo Therapeutics, Inc. (CYTH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CYTH · as of Jun 9, 2026
Key Statistics
Explore Cyclo Therapeutics, Inc. Data
cyth stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 33.3%
The CYTH analyst consensus is Hold, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $0.95, representing +31.83% upside from the current price of $0.72.
Competitors & Peers
cyth competitorsCYTH
ELEV
ELUT
HEXO
IVC
LSBStock Performance
Full HistoryAbout Cyclo Therapeutics, Inc.
Cyclo Therapeutics, Inc. operates as a clinical-stage biotechnology enterprise focused on developing treatments derived from cyclodextrins for various health conditions. Its flagship therapeutic candi…
what is cyclo therapeutics, inc. · cyth stock overview · cyclo therapeutics, inc. company profile · who is cyclo therapeutics, inc. ceo · cyth NASDAQ · cyclo therapeutics, inc. headquarters · cyclo therapeutics, inc. business segments
About Stock Overview & Key Data
Cyclo Therapeutics, Inc. (CYTH) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since May 3, 2000. As of the latest trading session, CYTH stock price is $0.72, with a market capitalization of $23.6M. The stock has returned -44.14% over the past 12 months and +20.10% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Cyclo Therapeutics, Inc. stock is Hold, with an average 12-month price target of $0.95. In fiscal year 2023, Cyclo Therapeutics, Inc. reported revenue of $1.1M and net income of -$20.1M. For detailed data — including Cyclo Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cyclo Therapeutics, Inc. (CYTH) stock price is $0.72. The stock is traded on NASDAQ under the ticker symbol CYTH. The 52-week range is $0.55 – $1.62.